Additional file 4: of Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians’ perceptions of language barriers in six European countries

Screening for viral hepatitis in Sexual Health Services/by Genit-Urinary Medicine specialist clinics survey. (PDF 344 kb

Soluble form of the scavenger receptor for hemoglobin (sCD163) in pregnancies complicated by preterm prelabor rupture of membranes

Preterm prelabor rupture of membranes (PPROM) is responsible for approximately 30% of all preterm deliveries. Histological chorioamnionitis (HCA) has been found in 50-80% of PPROM cases and is associated with higher rates of adverse maternal and neonatal outcome. The scavenger receptor for hemoglobin (CD163) is a transmembrane glycoprotein expressed almost exclusively on monocytes and macrophages. Its main function is the binding of hemoglobin-haptoglobin complexes. CD163 also serves as a surface receptor that recognizes intact bacteria and triggers cytokine production function. Moreover, it participates in the late down-regulatory phase of both acute and chronic inflammation. The soluble form of CD163 (sCD163) most likely represents the extracellular domain of CD163, which can be shed from the surface and released into the body fluid. The main aim of this thesis was to investigate sCD163 in pregnancy complicated by PPROM and relationships with HCA and funisitis. The first specific aim was to determine amniotic fluid sCD163 levels in uncomplicated pregnancies. Amniotic fluid samples were taken from 31 women who underwent amniocentesis for genetic testing in the second trimester, as well as from 32 women at term, 21 of whom had and 11 of whom did not have uterine contractions. The sCD163 levels in..

Epidemiology, key events and media attention during the A/H1N1 pandemic in Czech Republic.

<p>Detailed data on the (i) number of new A/H1N1 cases per week, (ii) reported number of confirmed A/H1N1 deaths and (iii) media attention are provided in the supplementary file ‘<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.s001" target="_blank">S1 Data’</a>. Data on vaccination coverage was taken from Mereckiene et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.ref004" target="_blank">4</a>] and data on risk perception from the Flash Eurobarometer survey [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.ref025" target="_blank">25</a>]. Data on key events are provided in ‘<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.s002" target="_blank">S1 File’</a>.</p

Epidemiology, key events and media attention during the A/H1N1 pandemic in Germany.

<p>Detailed data on the (i) number of new A/H1N1 cases per week, (ii) reported number of confirmed A/H1N1 deaths, (iii) media attention and (iv) vaccination uptake are provided in ‘<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.s001" target="_blank">S1 Data’</a>. Data on vaccination coverage was taken from Mereckiene et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.ref004" target="_blank">4</a>] and data on risk perception from the Flash Eurobarometer survey [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.ref025" target="_blank">25</a>]. Data on key events are provided in ‘<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0151258#pone.0151258.s002" target="_blank">S1 File’</a>.</p

Additional file 1: of Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries. The ‘Chronic Hepatitis B (CHB) Additional file 1’ includes 9 annexes. Annexs 1, 2, 5 and 7 present data on the search strategy, the PRISMA flow chart, the inclusion and exclusion criteria of global/worldwide systematic reviews and meta-analyses and the rationale for the selected country specific hepatitis B and C prevalence figures. (ii) Annexs 3, 4 and 6 present data on the search strategy, the PRISMA flow chart and the inclusion and exclusion criteria for chronic hepatitis B/C prevalence studies among migrants in the EU/EEA. (iii) Annex 8 presents a list of the country specific HBsAg prevalence estimates selected along with the corresponding source. (iv) Annex 9 presents country tables which list the estimated number of Chronic Hepatitis B (CHB) cases among the 50 largest migrant populations residing in the individual EU/EEA host countries. (DOCX 487 kb

Additional file 2: Tables 2, 3, 4 and 6 with data presented in absolute numbers. of Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey

Health professionals reporting the existence of national general hepatitis B and C guidelines in their country. Table 3. Health professionals identifying hepatitis general or specific guidelines by professional group and by country. Table 4. Availability of training to improve knowledge and skills in viral hepatitis in the six countries. Table 6. Health professionals’ opinion on the existence of barriers as explanations of why hepatitis B/C cases do not reach specialized health care (e.g. hepatologists) for further investigation and treatment. Results are presented by country. (DOCX 23 kb

Additional file 1: Table S1. of Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey

Hepatitis B/C related guidance documents retrieved by the literature search and/or identified by experts. (DOCX 36 kb